Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,019,095
+$319,042 QoQ
Shares Held
607,376
-34.7% QoQ
Ownership
0.902%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 183 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Derivatives in DNA
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
0
PutValue
$66,733
PutShares
4,995
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. DNA ranks #184 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in DNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,019,095 | 607,376 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,700,053 | 929,862 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,639,457 | 919,309 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $12,032,698 | 825,288 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,856,488 | 1,142,799 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,914,571 | 686,767 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $5,377,834 | 547,641 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,991,376 | 367,040 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $66,733 | 199,800 | Put | Defined | 2024-08-13 | |
| 2024-06-30 | $1,863,952 | 5,580,702 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,510,607 | 2,164,318 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $231,768 | 199,800 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $1,189,896 | 704,081 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $1,819,948 | 1,005,497 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $824,329 | 443,188 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $304,461 | 228,919 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,522,657 | 1,492,697 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $202,800 | 120,000 | Call | Defined | 2024-05-14 | |
| 2022-12-31 | $340,873 | 201,700 | Put | Defined | 2024-05-14 | |
| 2022-09-30 | $3,394,825 | 1,088,085 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $629,304 | 201,700 | Put | Defined | 2024-05-14 | |
| 2022-06-30 | $10,101,314 | 4,244,250 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $480,046 | 201,700 | Put | Defined | 2024-05-14 | |
| 2022-03-31 | $403,000 | 100,000 | Put | Defined | 2022-05-16 | |
| 2022-03-31 | $1,289,172 | 319,894 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||